Inventor · Slough, GB

Stephen Edward Rapecki

28Patents
7h-index
33Co-inventors
65Inventor score

Filing activity: Nov 16, 2005 → Aug 23, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8303953B2 Antibody molecules which bind IL-17A and IL-17F Chemistry; Metallurgy 13 Active
US8231875B2 Neutralising antibody molecules having specificity for human IL-17 Chemistry; Metallurgy 13 Active
US10358493B2 Bispecific format suitable for use in high-through-put screening Chemistry; Metallurgy 13 Active
US10370447B2 Molecules with specificity for CD79 and CD22 Chemistry; Metallurgy 13 Active
US10705094B2 TNF receptor signaling modulator assay Physics 9 Active
US10590197B2 Antibody molecules which bind CD22 Chemistry; Metallurgy 8 Active
US10618957B2 Antibody molecules which bind CD79 Chemistry; Metallurgy 7 Active
US10775385B2 Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers Physics 7 Active
US10883996B2 Methods of identifying signaling modulators of the trimeric TNFa Physics 6 Active
US10829566B2 Method employing bispecific antibodies Chemistry; Metallurgy 6 Active
US8329431B2 Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17 Chemistry; Metallurgy 6 Active
US10774152B2 Molecules with specificity for CD45 and CD79 Chemistry; Metallurgy 5 Active
US8057794B2 Antibody molecules which bind to human IL-17 Chemistry; Metallurgy 5 Active
US7931900B2 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity Chemistry; Metallurgy 4 Active
US10208349B2 Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy Chemistry; Metallurgy 4 Active
US8435761B2 DNA encoding antibody molecules which bind human IL-17 Chemistry; Metallurgy 4 Active
US11448655B2 Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors Physics 1 Active
US8617847B2 Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F Chemistry; Metallurgy 1 Active
US11261252B2 Molecules with specificity for CD79 and CD22 Chemistry; Metallurgy 1 Active
US11472879B2 Antibody molecules which bind CD22 Chemistry; Metallurgy 1 Active
US9890219B2 Methods of treating an IL-17A mediated pathological condition Chemistry; Metallurgy 1 Active
US11674967B2 Method of identifying potential inhibitors of APO TNFα trimers Physics 1 Active
US10308723B2 Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F Chemistry; Metallurgy 1 Active
US8865167B2 Neutralising antibody molecules having specificity for human IL-17 Chemistry; Metallurgy 1 Active
US11466324B2 Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.